BioXcel Therapeutics (BTAIQ) Non Operating Interest Expenses (2019 - 2026)
BioXcel Therapeutics (BTAIQ) reported Non Operating Interest Expenses of $4.26 million for Q2 2026, up 0.8% from $4.22 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioXcel Therapeutics' Non Operating Interest Expenses came in at $17.22 million, up 7.4% year-over-year; for FY2025, it was $16.98 million, up 12.3% from FY2024.
- Non Operating Interest Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 262.9% (FY2020 to FY2025).
- By year, Non Operating Interest Expenses came in at $15.13 million in FY2024 (+13.6%), $13.31 million in FY2023 (+62.1%), $8.21 million in FY2022 and $40,000 in FY2021 (+48.1%).
- Five-year quarterly Non Operating Interest Expenses spans a low of $6,000 in Q4 2021 and a high of $4.4 million in Q4 2025.
- Year over year, Non Operating Interest Expenses has now increased in each of the last 11 quarters, with growth averaging 11.1% over the last eight quarters.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2021 (growth of 120.0%); the low point was Q3 2023 (a decline of 12.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.2 million (Q1 2026), $4.4 million (Q4 2025) and $4.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 4.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 4.37 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 3.25 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 11,000.00 |
API Access
BioXcel Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();